You can find the annual or quarterly income statement of Satellos Bioscience Ord Shs here for insights into the performance and operational efficiency of Satellos Bioscience Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

Operating expenses

--5.59M

--7.65M

R&D expenses

--5.59M

--5.46M

Depreciation, depletion, and amortization

--1.00K

Other operating expenses

---387.00K

--153.00K

Operating profit

---10.04M

---7.65M

Net non-operating interest income (expenses)

Non-operating interest income

--421.00K

--256.00K

Gains from sale of securities

---113.00K

--146.00K

Special income (expenses)

----

--0.00

Income before tax

---9.73M

---7.25M

Income tax

--33.00K

--58.00K

Income after tax

---9.77M

---7.30M

Net income from continuous operations

---9.77M

---7.30M

Net income attributable to controlling interests

---9.77M

---7.30M

Net income attributable to common shareholders

---9.77M

---7.30M

Basic earnings per share

---0.53

---0.47

Diluted earnings per share

---0.53

---0.47

Dividend per share

----

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

